Vacunacionadultos

Should You Buy a Basket of Late-Stage Coronavirus Vaccine Stocks?

There’s no question which drugmakers are leading the coronavirus vaccine race. Of the 48 candidates in clinical testing, 11 are in late-stage clinical studies, according to the World Health Organization. 



a close up of a basket: Should You Buy a Basket of Late-Stage Coronavirus Vaccine Stocks?


© Provided by The Motley Fool
Should You Buy a Basket of Late-Stage Coronavirus Vaccine Stocks?

We can whittle this list down further for U.S. investors. Only six public companies with late-stage COVID-19 vaccine candidates trade on U.S. stock exchanges. Some investors will attempt to pick the stock they deem most likely to be the biggest winner from among this group.

However, there is another potential approach: buying a basket of late-stage coronavirus vaccine stocks. Could this be a better strategy for investors?



a close up of a basket: Basket full of cash with cash surrounding it.


© Getty Images
Basket full of cash with cash surrounding it.

Filling the basket

Two late-stage COVID-19 vaccines appear to be the closest to potentially reaching the U.S. market. Pfizer and BioNTech announced great efficacy results for

Read More